Parkinson’s disease is not preferentially inherited from either your mother or your father in most cases. The vast majority of Parkinson’s cases, roughly 85%, are sporadic, meaning they occur in people with no family history of the disease at all. For the remaining 15% with a family connection, the known genetic risk factors sit on regular chromosomes, not on sex-linked ones, so they can be passed down equally from either parent. There is one narrow exception involving mitochondrial DNA, which comes exclusively from your mother, but its role in Parkinson’s risk is still being studied and appears to be a minor contributor compared to other factors.
Why Most Cases Aren’t Inherited at All
Parkinson’s is primarily a disease of complex interactions between your genes and your environment rather than a condition passed down through a family tree. Only about 15% of people with Parkinson’s have a family history of the disorder. The rest develop it through a combination of environmental exposures, aging, and subtle genetic vulnerabilities that don’t follow a neat inheritance pattern. Environmental pollutants, for example, can alter how your genes are expressed without changing the DNA itself, a process called epigenetic modification. These changes can accelerate the kind of nerve cell damage that characterizes Parkinson’s.
This means that even if neither of your parents had Parkinson’s, you could still develop it. And if one parent did have it, you are far from guaranteed to get it yourself.
Genes That Increase Risk Come From Either Parent
When Parkinson’s does run in families, the mutations responsible sit on autosomal chromosomes (the 22 pairs that aren’t sex chromosomes). This means a father and a mother are equally capable of passing them on. Two of the most studied genes illustrate this well.
The LRRK2 gene is the most common genetic contributor to Parkinson’s. A specific LRRK2 mutation is particularly prevalent among people of Ashkenazi Jewish and North African Berber descent. But carrying this mutation is far from a death sentence: among people with the mutation, only about 26% develop Parkinson’s by age 80. The rest never do. That incomplete conversion from gene carrier to actual patient, known as penetrance, is a key reason genetic Parkinson’s doesn’t behave like a straightforward inherited disease.
The GBA gene tells a similar story. In studies of Ashkenazi Jewish populations, about 18% of Parkinson’s patients carried a GBA mutation compared to roughly 4 to 6% of people without the disease. Mild GBA mutations are relatively common in this population (about 1 in 17 people carry one), yet most carriers never develop Parkinson’s. Again, either parent can pass this gene along.
The Maternal Link Through Mitochondrial DNA
There is one biological pathway that is exclusively maternal. Mitochondria, the structures inside your cells that produce energy, carry their own small set of DNA. You inherit all of your mitochondrial DNA from your mother, with zero contribution from your father. Since mitochondrial dysfunction is a well-recognized feature of Parkinson’s, researchers have investigated whether variations in mitochondrial DNA could contribute to disease risk.
A study published in Frontiers in Aging Neuroscience found that certain mitochondrial DNA variants occurred significantly more often in Parkinson’s patients of African ancestry than in controls. These “out-of-place” variants, mitochondrial DNA sequences that appear on an unexpected maternal lineage, may interfere with normal energy production in brain cells. However, studying mitochondrial DNA’s role in Parkinson’s is complicated by features unique to this genome, including the fact that cells can carry a mix of normal and mutated mitochondrial DNA, and problems only emerge when the proportion of mutated copies crosses a certain threshold.
So while there is a plausible biological reason that maternal inheritance could matter slightly more, the effect appears small relative to the autosomal genes and environmental factors that drive most Parkinson’s risk.
Your Actual Risk With a Family History
If one of your parents (or a sibling) has Parkinson’s, your risk roughly doubles compared to someone with no family history. A large study in Neurology found that first-degree relatives of Parkinson’s patients were 2.3 times more likely to develop the disease. But the absolute numbers tell a more reassuring story: the cumulative chance of developing Parkinson’s by age 75 was about 2% for people with an affected first-degree relative, compared to 1% for people without one. That means even with a parent who has Parkinson’s, there is a 98% chance you will not develop it by that age.
These numbers hold regardless of whether the affected parent is your mother or your father. The doubling of risk is the same either way.
When Genetic Testing Makes Sense
Genetic testing for Parkinson’s is not routine. It is generally recommended in specific situations: if symptoms begin before age 50, if a first-degree relative was diagnosed before age 50, or if unusual neurological features are present alongside parkinsonism (such as early cognitive decline, difficulty with balance and coordination, or abnormal eye movements).
For most people with a parent diagnosed in their 60s or 70s, genetic testing is unlikely to change medical management. The known mutations account for only a fraction of familial cases, and even a positive result cannot predict whether you will actually develop the disease. If you are considering testing, a genetic counselor can help you interpret what the results would and wouldn’t tell you, especially given the low penetrance rates of mutations like LRRK2 and GBA.
What Actually Drives Risk
The clearest picture of Parkinson’s risk looks less like a family tree and more like a web. Your genes set a baseline vulnerability, environmental exposures (certain pesticides, industrial solvents, head injuries) can push that vulnerability higher, and aging itself is the single strongest risk factor. Epigenetic changes, modifications that affect how genes are read without altering the DNA sequence, act as a bridge between environmental exposures and the nerve cell degeneration that defines Parkinson’s.
For someone wondering whether their mother’s or father’s diagnosis puts them at greater risk, the honest answer is that neither parent’s diagnosis carries more weight than the other. The small maternal-only pathway through mitochondrial DNA exists, but it is dwarfed by the autosomal genes and environmental factors that shape most people’s risk. The most practical takeaway: having one parent with Parkinson’s raises your absolute lifetime risk only modestly, and there is no evidence that the sex of the affected parent changes that number in a clinically meaningful way.